Terra Innovatum Advances SOLO™ Construction Permit Application and Reactor Procurement, Reaffirms Fully Funded Path to 2027 First-Of-A-Kind Deployment
Major reactor equipment is under procurement, while formal construction-permit submission remains ahead.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Terra Innovatum (NKLR) has shared 12 draft safety-report chapters with U.S. nuclear regulators as it advances its SOLO reactor construction-permit application. The chapters represent 12 of 18 planned sections of its Preliminary Safety Analysis Report. The company targets delivery of the remaining six by October 30, 2026 and expects the next readiness-review milestone by the end of November, subject to NRC scheduling. Formal application submission is expected after the readiness review.
Terra Innovatum targets its first reactor deployment in 2027 and broader deployment beginning in 2028. It expects existing resources to cover the first reactor's licensing, manufacturing, construction and initial operations without additional equity under its current plan; cash and cash equivalents totaled $91.1 million at June 30, 2026. Procurement and down payments have begun for graphite components, a turbine and generator, and an air-cooled condenser.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.Existing resources are expected to fund the first reactor through initial operations without additional equity under the current plan.
- Moderate pointCash and cash equivalents totaled $91.1 million as of June 30, 2026.
- Moderate point. Forward-looking: it has not happened yet and may not happen.First SOLO reactor deployment is targeted for 2027, with broader deployment targeted to begin in 2028.
- Minor pointLicensing progress includes 12 of 18 draft safety-report chapters shared with NRC staff.
- Minor point. Forward-looking: it has not happened yet and may not happen.Remaining six draft chapters are targeted for delivery by October 30, 2026.
3 minor points
- Minor pointProcurement and down payments have begun for Mersen graphite, Howden turbine-generator equipment and SPG Dry Cooling condenser.
- Minor pointSupplier identification and engagement cover approximately 80% of anticipated suppliers.
- Minor pointManufacturing work with ATB Riva Calzoni and Boldrocchi includes assembly planning, process development and helium-circulation equipment testing.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.Formal construction-permit application submission remains pending and is expected after completion of the readiness review.
- Moderate pointOrders for shutdown, instrumentation and control systems, valves and steam generator remain in advanced discussions.
- Minor point. Forward-looking: it has not happened yet and may not happen.The next readiness-review milestone is expected by end-November 2026, subject to NRC scheduling and regulatory processes.
News Explained
Terra says it has identified and is working with approximately
Details
Market move: NKLR -4.28% vs previous close. Construction permit application update
On Oct 22, the day this news came out, the latest delayed price for NKLR is 4.28% below the previous close. Our momentum scanner has recorded 5 alerts for this stock so far that day. The latest delayed price is $2.13.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Draft PSAR chapters shared
- 12 of 18 chapters
- Shared with NRC staff for construction permit application readiness review
- Remaining draft chapters
- 6 chapters by October 30, 2026
- Target delivery
- Next readiness-review milestone
- By the end of November 2026
- Subject to NRC scheduling
- Cash and cash equivalents
- $91.1 million
- As of June 30, 2026
- Anticipated suppliers identified
- Approximately 80%
- Suppliers identified and being worked with; purchase orders and payments progress separately
- First reactor deployment target
- 2027
- Targeted first-of-a-kind SOLO reactor deployment
Historical Context
-
Advanced manufacturing preparations with partners and tested helium circulation equipment for the SOLO program.
-
NRC began a limited-scope readiness assessment of planned construction permit application materials.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
psar regulatory
construction permit application regulatory
low-enriched uranium technical
instrumentation and control technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company shares 12 of 18 draft PSAR chapters with NRC for readiness review, targets remaining six by October 30
Major reactor components secured or under procurement as Company advances toward fully funded 2027 first-of-a-kind deployment
NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. (NASDAQ: NKLR) ("Terra Innovatum" or the "Company"), developer of the SOLO™ Micro-Modular Reactor, today announced continued progress in its U.S. Nuclear Regulatory Commission ("NRC") licensing program, having now shared 12 of 18 planned chapters of its Preliminary Safety Analysis Report ("PSAR") with NRC staff as part of the ongoing construction permit application readiness assessment.
The Company expects to provide the remaining six draft chapters by October 30, 2026, and anticipates the next readiness-review milestone by the end of November, subject to NRC scheduling.
These developments, together with continued progress in the procurement of major reactor components and preparations for industrial manufacturing, reflect Terra Innovatum's advancement toward its targeted first-of-a-kind ("FOAK") SOLO™ reactor deployment in 2027. Importantly, the Company continues to expect that its existing financial resources will be sufficient to fund the licensing, manufacturing, construction and initial operations of its first reactor without requiring additional equity financing under its current deployment plan.
Advancing Toward Completion of Construction Permit Application
Terra Innovatum continues to execute its regulatory strategy through a structured program of technical documentation, preapplication engagement and ongoing coordination with NRC staff.
The Company's latest progress, including additional draft PSAR chapters shared with the NRC on October 19, brings the total to 12 of 18 planned chapters.
Terra Innovatum is targeting delivery of the remaining six chapters by October 30, marking an important milestone in the preparation of its Construction Permit Application ("CPA").
The Company's ongoing preapplication readiness assessment with NRC staff is designed to identify and address technical questions, information requirements and potential licensing issues in advance of formal CPA submission. The complete PSAR is expected to be formally submitted as part of the CPA following completion of the readiness-review process.
The Company currently anticipates the next readiness-review milestone by the end of November 2026, subject to NRC scheduling and regulatory processes.
Fully Funded Path to First-of-a-Kind Deployment
Terra Innovatum continues to expect that its existing financial resources will be sufficient to fund the licensing, manufacturing, construction and initial operations of its first SOLO™ reactor, without requiring additional equity capital under its current deployment plan.
The Company reported
Terra Innovatum believes this financial position is a meaningful competitive advantage in the emerging advanced nuclear industry, allowing the Company to remain focused on achieving key regulatory, manufacturing and deployment milestones while maintaining capital discipline.
The Company's strategy is built around a capital-efficient operating model that leverages established industrial manufacturing partners, commercially available components and an outsourced manufacturing approach designed to limit the need for substantial investment in dedicated production infrastructure.
Advancing First-of-a-Kind Reactor Procurement and Industrial Manufacturing
In parallel with its licensing activities, Terra Innovatum continues to make tangible progress toward the physical realization of its first SOLO™ reactor, advancing the procurement of major equipment and components alongside its industrial manufacturing program.
The Company has already initiated procurement and made down payments for several critical components of its first reactor, including graphite components from Mersen, the turbine and generator from Howden, and the air-cooled condenser from SPG Dry Cooling. Terra Innovatum is also in advanced discussions to finalize orders for the remaining major equipment packages, including the reactor shutdown system, instrumentation and control ("I&C") systems, valves and steam generator.
As of today, Terra Innovatum has identified and is working with approximately
Significantly, these components are being procured for the Company's first-of-a-kind reactor intended for deployment, rather than for a laboratory prototype or experimental demonstration system. This distinction reflects the maturity of the SOLO™ design and Terra Innovatum's progression beyond conceptual engineering toward the procurement, manufacturing and integration of equipment intended for its first operating reactor.
This procurement activity is complemented by continued progress across the Company's established industrial manufacturing network. As announced on October 14, Terra Innovatum advanced its first-of-a-kind manufacturing program with ATB Riva Calzoni and Boldrocchi, including reactor assembly planning, manufacturing-process development and testing of critical helium circulation equipment.
Collectively, these activities demonstrate the Company's increasingly integrated approach to licensing, procurement and manufacturing execution, with key workstreams progressing in parallel to support its targeted 2027 deployment.
SOLO™ is designed to utilize commercially available components and conventional low-enriched uranium ("LEU") fuel, including standard
The Company's first-of-a-kind reactor is designed to establish the manufacturing, licensing and operating foundation for subsequent commercial SOLO™ installations, with broader deployment targeted to begin in 2028.
Management Commentary
"Terra Innovatum continues to execute against the milestones we have established for bringing SOLO™ to market," said Alessandro Petruzzi, Co-Founder and Chief Executive Officer of Terra Innovatum. "With 12 of 18 planned PSAR chapters now shared with the NRC, we are approaching another important milestone in our licensing program. At the same time, we are translating years of engineering and design work into tangible industrial execution, with major equipment already under procurement and our manufacturing partners preparing for construction of our first reactor."
"What is particularly important is that the equipment we are procuring is intended for our first deployed SOLO reactor, not for a prototype or experimental demonstration. We are advancing the actual systems and components required to build and operate our first unit. This reflects our confidence in the maturity of the design and our focus on moving directly toward deployment."
"Equally important, we believe we have the financial resources necessary to execute our first-of-a-kind deployment plan without requiring additional equity financing. The combination of regulatory progress, active procurement of major reactor components, an established industrial supply chain and a funded deployment plan positions Terra Innovatum to remain focused on execution and achieving our 2027 deployment objective."
ABOUT TERRA INNOVATUM & SOLO™
Terra Innovatum is advancing innovative, sustainable nuclear energy solutions through the SOLO™ Micro-Modular Reactor. Conceptualized in 2018 and engineered over six years by experts in nuclear safety, licensing and R&D, SOLO™ is designed for efficient today’s world commercial deployment; using readily available commercial components to reduce supply-chain risk and improve cost predictability. Running on the only commercially available and non-proliferant fuel LEU, its flexible platform is designed to support LEU+ and transition to future fuel options, including HALEU.
SOLO™ is designed to provide CO₂-free, behind-the-meter and off-grid consistent power and heat for data centers, remote communities and energy-intensive industries including cement, oil and gas, steel and mining, desalination, water treatment and co-generation, as well as defense installations. Its modular architecture can scale from individual units of 1MWe to deployments of 1 GW or more, while also supporting specialized applications such as medical radioisotope production.
To learn more, visit: https://investors.terrainnovatum.com/.
Follow us on X: https://x.com/TerraInnovatum
and LinkedIn: https://www.linkedin.com/company/terra-innovatum-solo/.
CONTACTS
Giordano Morichi
Founding Partner, Managing Director of Global Business Development and Investor Relations
Terra Innovatum Global N.V.
E: g.morichi@terrainnovatum.com
W: www.terrainnovatum.com
Investor and Media Relations
Simon Willcocks, Alliance Advisors IR
E: investors@terrainnovatum.com
FORWARD-LOOKING STATEMENTS
This press release includes “forward-looking statements” within the meaning of the federal securities laws, including, but not limited to, opinions and projections prepared by Terra Innovatum’s management. Forward-looking statements generally relate to future events or future financial or operating performance, including pro forma and estimated financial information, and other “forward-looking statements” (as such term is defined in the Private Securities Litigation Reform Act of 1995). The recipient can identify forward-looking statements because they typically contain words such as “outlook,” “believes,” “expects,” “will,” “projected,” “continue,” “increase,” “may,” “should,” “could,” “seeks,” “predicts,” “intends,” “trends,” “plans,” “estimates,” “anticipates” or the negatives or variations of these words or other comparable words and/or similar expressions (but the absence of these words and/or similar expressions does not mean that a statement is not forward-looking).
These forward-looking statements specifically include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics, projections of market opportunity and market share, expected timing for regulatory approvals and commercialization and the potential success of Terra Innovatum’s strategy and expectations. Forward-looking statements, opinions and projections are neither historical facts nor assurances of future performance. Instead, they are based only on current beliefs, expectations and assumptions regarding the future of Terra Innovatum’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Terra Innovatum’s control. These uncertainties and risks may be known or unknown.
Factors that may cause actual results to differ materially from current expectations include, but are not limited to: changes in domestic and foreign business, market, financial, political and legal conditions; future global, regional or local economic and market conditions; the development, effects and enforcement of laws and regulations; Terra Innovatum’s ability to manage future growth; Terra Innovatum’s ability to develop new products and services, bring them to market in a timely manner, and make enhancements to its platform; the effects of competition on Terra Innovatum’s future business; and the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries and other risks and uncertainties described under the heading “Risk Factors” in documents Terra Innovatum files from time to time with the Securities and Exchange Commission including Form 10-Q for the quarter ended June 30, 2026. If any of these risks materialize or Terra Innovatum’s assumptions prove incorrect, actual results could differ materially from the results implied by the forward-looking statements contained herein. In addition, forward-looking statements reflect Terra Innovatum’s expectations and views as of the date of this press release. Terra Innovatum anticipates that subsequent events and developments will cause its assessments to change. However, while Terra Innovatum may elect to update these forward-looking statements in the future, it specifically disclaims any obligation to do so. Accordingly, you should not place undue reliance on the forward-looking statements, which speak only as of the date they are made.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How far has Terra Innovatum progressed with the SOLO construction-permit application?
Terra Innovatum has shared 12 of 18 planned draft safety-report chapters with NRC staff for a preapplication readiness assessment. The remaining six are targeted for October 30, 2026. Formal submission of the complete report as part of the construction-permit application is expected after the readiness-review process.
Does Terra Innovatum expect to need more equity financing for its first SOLO reactor?
Terra Innovatum expects its existing resources to fund licensing, manufacturing, construction and initial operations of the first reactor without additional equity financing under its current deployment plan. Cash and cash equivalents were $91.1 million as of June 30, 2026; first deployment remains targeted for 2027.
Does Terra Innovatum's 80% supplier figure mean SOLO equipment orders are complete?
No. The approximately 80% figure covers anticipated suppliers identified and engaged, not completed equipment orders. Purchase orders and payments are progressing separately by equipment package. Orders for the reactor shutdown system, instrumentation and control systems, valves and steam generator remain in advanced discussions.